On the 1st of March 2016, a team of both VPHi and Alliance members presented in details the goals and working plans of the new Avicenna Alliance for 2016
The Avicenna Alliance is a partnership with industry that will focus on promoting the in silico medicine market. With a 50-50 representation of industry and VPHi members, the Alliance will work toward addressing barriers to the uptake of VPH solutions.
As major objective of 2016, the Alliance is planning the imminent launch of 3 important working groups, that will focus on these key areas:
The participation to these working groups is open to all VPHi members, so in case you're interested to join, don't hesitate to contact us: email@example.com
If you haven't had the chance to attend the webinar, the video recording is available for you to view on YouTube.